Mirae Asset Global Investments’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.54K | Buy |
7,656
+1,260
| +20% | +$1.24K | ﹤0.01% | 1521 |
|
|
2025
Q1 | $9.59K | Sell |
6,396
-170
| -3% | -$255 | ﹤0.01% | 1474 |
|
|
2024
Q4 | $15K | Buy |
+6,566
| New | +$15K | ﹤0.01% | 1461 |
|
|
2023
Q1 | – | Sell |
-26,267
| Closed | -$164K | – | 2550 |
|
|
2022
Q4 | $164K | Buy |
26,267
+204
| +0.8% | +$1.27K | ﹤0.01% | 2345 |
|
|
2022
Q3 | $174K | Buy |
26,063
+8,044
| +45% | +$53.7K | ﹤0.01% | 2385 |
|
|
2022
Q2 | $114K | Buy |
+18,019
| New | +$114K | ﹤0.01% | 2283 |
|
|
2015
Q4 | – | Sell |
-47,500
| Closed | -$1.12M | – | 463 |
|
|
2015
Q3 | $1.12M | Buy |
47,500
+25,480
| +116% | +$601K | 0.05% | 279 |
|
|
2015
Q2 | $1.8M | Buy |
22,020
+6,590
| +43% | +$539K | 0.06% | 224 |
|
|
2015
Q1 | $1.43M | Buy |
+15,430
| New | +$1.43M | 0.05% | 251 |
|